Answers are grounded in this paper and cite their sources.
. No differences in imaging response or PFS correlates were found for different treatment cohorts. Conclusion Quantitative total bone imaging enables comprehensive disease quantification on NaF PET/CT imaging, showing strong correlation to clinical outcomes. Total functional burden assessed after three cycles of hormonal therapy or chemotherapy was predictive of PFS for men with mCRPC. This supports ongoing development of NaF PET/CT-based imaging biomarkers in mCRPC to bone.
No takes yet. Share an insight, caveat, or question.
Harmon et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: